Atea Pharmaceuticals Inc banner

Atea Pharmaceuticals Inc
NASDAQ:AVIR

Watchlist Manager
Atea Pharmaceuticals Inc Logo
Atea Pharmaceuticals Inc
NASDAQ:AVIR
Watchlist
Price: 5.76 USD 1.95% Market Closed
Market Cap: $458.9m

Wall Street
Price Targets

AVIR Price Targets Summary
Atea Pharmaceuticals Inc

Wall Street analysts forecast AVIR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AVIR is 8.16 USD with a low forecast of 6.06 USD and a high forecast of 10.5 USD.

Lowest
Price Target
6.06 USD
5% Upside
Average
Price Target
8.16 USD
42% Upside
Highest
Price Target
10.5 USD
82% Upside
Atea Pharmaceuticals Inc Competitors:
Price Targets
PACB
Pacific Biosciences of California Inc
71% Upside
SPH
Suburban Propane Partners LP
-12% Downside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AVIR's stock price target?
Price Target
8.16 USD

According to Wall Street analysts, the average 1-year price target for AVIR is 8.16 USD with a low forecast of 6.06 USD and a high forecast of 10.5 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett